James O. Armitage, Director at Cardiff Oncology, Inc. (CRDF), bought 13,000 shares at $1.56 ($20K) on 2022-09-16, disclosed to the SEC on 2022-10-11.
Open-market purchase of $20k CRDF by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| TSRO | SELL | 2017-09-20 | $2.3M | — | Filing → |
| TSRO | BUY | 2015-09-09 | $27K | — | Filing → |
| TSRO | BUY | 2014-12-15 | $38K | — | Filing → |